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ing by ElAbstract The aim of this work was to evaluate the ability of Diffusion MRI using different b val-
ues in detection and characterization of liver hemangiomas in order to differentiate them from other
focal hepatic lesions.
Patients and methods: Thirty one hemangiomas in 28 patients were examined with diffusion MR
using different four b values: 200, 500, 800 and 1000 s/mm2. Hemangiomas were divided into typical
and atypical lesions. Lesions were evaluated regarding size, enhancement pattern, signal intensity
and ADC maps in conventional and diffusion MR.
Results: All hemangiomas showed hyperintense signal at diffusion MR with different b values. In
typical and atypical hemangiomas, diffusion MR showed hyperintense signal that persisted with
increasing b values. Both types showed hyperintense signal or mixed signals in ADC maps. Mean
ADC values (for both types) were 2.47, 2.36, 2.31 and 2.10 · 103 mm2/s for b 200, 500, 800 and
1000, respectively. Arterial nodular enhancement pattern of atypical hemangiomas showed signiﬁ-
cant increased ADC value than other types.
Conclusion: DWI can successfully detect and characterize hepatic hemangiomas, it provides qual-
itative and quantitative assessment of hemangiomas. The combination of diffusion signal intensity01060338481.
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358 J.A. Mazroa, S.A. Elmogy& ADC maps and values successfully differentiates hemangiomas from other focal lesions rather
than signal intensity changes in different b values.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Hemangiomas present a diagnostic challenge because they can
be mistaken for hyper-vascular malignancies of the liver and
can coexist with (and occasionally mimic) other benign and
malignant hepatic lesions, including focal nodular hyperplasia,
hepatic adenoma, hepatic cysts, hemangio-endothelioma,
hepatic metastasis, and primary hepatocellular carcinoma
(1–3). Hemangiomas are encountered in about 7–20% of the
population. The radiologic imaging plays a critical role in
the differential diagnosis of these lesions. On post contrast
computed tomography (CT) and magnetic resonance (MR)
images, most hemangiomas have typical arterial peripheral
nodular enhancement. However, atypical hemangiomas (which
showed arterial nodular or delayed enhancement) may imitate
metastases. The differential diagnosis of these lesions is essen-
tial to determine the therapy. A variety of radiologic imaging
are currently available for the clinical use in these cases. Tri-
phasic CT scan has been widely used in the differential diagno-
sis, however, this technique is relatively invasive and the results
are not always reliable (4–6).
Magnetic resonance imaging plays an increasingly impor-
tant role in the evaluation of patients with liver disease because
of its high contrast resolution, lack of ionizing radiation, and
the ability of performing functional imaging sequences. With
advances in hardware and coil systems, diffusion-weighted
(DW) MR imaging can now be applied to liver imaging with
improved image quality. DW MR imaging enables qualitative
and quantitative assessment of tissue diffusivity (apparent dif-
fusion coefﬁcient) without the use of gadolinium chelates,
which is hazardous in patients with severe renal dysfunction
at risk for nephrogenic systemic ﬁbrosis (7–11).
The use of DWI in the detection and characterization of fo-
cal hepatic lesions has gained recent interest. Many studies
have proposed that diffusion MR can help to detect, character-
ize and distinguish benign from malignant lesions based on dif-
fusion signal intensity using different b values and apparent
diffusion coefﬁcient (ADC) map and measurements. The the-
ory is that malignant lesions have restricted diffusion while be-
nign lesions do not, thus the ADC value of benign lesions is
signiﬁcantly higher than that of malignant lesions (7).
1.1. Aim of the study
The aim of the study was to evaluate the ability of Diffusion
MRI qualitatively and quantitatively using different b values
in detection and characterization of typical and atypical liver
hemangiomas in order to differentiate them from other focal
lesions.2. Patients and methods
This prospective study was conducted from June 2010 till June
2011, it included 28 patients with 31 liver hemangiomas. Le-sions were classiﬁed into typical and atypical types based on
triphasic CT scan; 19 were typical hemangiomas (showed arte-
rial peripheral nodular enhancement) and 12 were atypical
hemangiomas (9 showed arterial nodular enhancement and 3
showed delayed enhancement), 19 were females, 9 were males,
their ages ranged from 21 to 68 years with a mean age of 44.5
Y. Among our patients, 13 were discovered accidentally during
abdominal US for non malignant causes (like cholecystitis,
gastritis, colitis), 15 were discovered accidentally in metastatic
work up of patients with malignancy (7 cancer breast, 3 cancer
colon, 2 prostatic carcinoma, 2 bronchogenic carcinoma and
one non Hodgkin lymphoma). Patients with malignancy re-
ferred from surgery, and oncology departments of Mansoura
University Hospital for MRI, other patients came randomly
for abdominal US.
All patients performed abdominal US. Triphasic spiral CT
scan was done for 21 patients.
MRI was done for all patients: non contrast + diffusion
MR for all patients, additional post contrast MRI was done
for 7 patients. Maximum 3 days interval separated CT exami-
nation and MR examination.
Patients performed MRI using 1.5 T GE medical system
and a phased array head coil. Sequences obtained were the fol-
lowing: T2 SSFSE scout (axial, coronal, sagittal), respiratory
gated coronal T2FSE, axial T2 FSE FAT SAT, Diffusion
MR,T1SE in and out phases, heavy T2FSE, post contrast
Fat Sat T1SE. Post contrast study was done (after diffusion
scans) using bolus injection of Gadolinium in a dose of
0.1 m mol/kg body weight (average 15 ml in 10 s).
DWI MRI was obtained by single shot echo-planar imag-
ing (EPI) with spectral presaturation attenuated inversion-
recovery fat-suppressed pulse. DWI was performed with free-
breathing respiratory-triggered acquisition.
2.1. Single-shot echo-planar diffusion MR
TR/TE:9000/88.1, ﬂip angle, 90; slice thickness = 5, slice gab:
1 mm, NEX: 8, matrix: 128 · 128. Using different b values
(0 s/mm2, 200 s/mm2, 500 s/mm2, 800 s/mm2 and b= 1000 s/
mm2). Acquisition time = 2.23 min.
ADC maps were formed automatically by the device. The
mean ADC for each lesion was measured by drawing a region
of interest (ROI). If the lesion was larger than 3 cm, three
ROIs were carefully placed and those three measurements were
averaged, for every lesion, a mean ADC value was determined
by taking the mean of ADC measurements of successive slices.
For heterogeneous lesions, measurements were performed
from contrast enhanced solid parts on conventional sequences
and post-contrast images. ADCs were measured from each le-
sion for b-200, b-500, b-800 and b-1000 s/mm2 gradient values.
ADC values of the normal liver parenchyma (right and left
lobe) were also obtained in different b values and compared
to ADC values of hemangiomas.
The study protocol was approved by the ethical committee
of our university and all the patients gave informed consent.
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followed up by gray scale ultra sound for the remaining
6 months conﬁrming the stability of lesions.
2.2. Image analyses
MR images were reviewed on PACS (GE Medical Systems) to
detect hepatic hemangiomas, their site, size, signal intensity,
pattern of enhancement. Diffusion MR was analyzed in qual-
itative (signal intensity changes) and quantitative (ADC
values) ways in different b values.3. Results
The study included 28 patients with 31 hepatic hemangiomas.
Typical hemangiomas (19) showed arterial peripheral nodular
enhancement and atypical hemangiomas: (12) divided into: 9
patients showed arterial nodular enhancement and 3 patients
showed delayed enhancement.
Lesions size: ranged from 9 to 65 mm. All were solitary
lesions except in 3 patients who showed 2 lesions in each.
Lesions site: 26 lesions were located at RT. Lobe, 5 at LT.
lobe.
Lesions signal intensity: all hemangiomas showed hyperin-
tense signal at T2SE FAT SAT and heavy T2FSE.
Pattern of enhancement: divided hemangiomas into: typical
lesions which showed peripheral arterial nodular enhancement,
atypical lesions which showed either nodular arterial enhance-
ment or delayed enhancement. These imaging features were
shown in Table 1.
3.1. Diffusion MR, qualitative assessment
All hemangiomas showed hyperintense signal at diffusion
MRI.
* Typical and atypical hemangiomas in diffusion MR
images showed no change of the hyperintense signal with
increasing b values. Table 1 and Figs. 1–3.
3.2. ADC maps
* Both types showed either hyperintense signal or mixed sig-
nals (isointense + hyperintense) with different b values (Table
1).
3.3. Diffusion MR, quantitative assessment
– Mean ADC values of normal liver tissue at b 200, 500, 800 and
1000 were 3.31, 2.53, 1.79, 1.26 · 103 mm2/s, respectively.Table 1 Showing conventional and diffusion MR imaging features
MRI features S.Ia in T2FSE, heavy T2FSE Triphasic contra
Hemangiomas Arterial and por
Typical hemangioma Hyperintense Peripheral nodul
Atypical hemangioma Hyperintense 1-Nodular enhan
2-No enhanceme
a S.I: signal intensity.
b Mixed: hyperintense + isointense signals.– Mean ADC value of typical hemangiomas at b 200, 500, 800,
1000 were 2.46, 2.36, 2.29, 2.10 · 103 mm2/s, respectively.
– Mean ADC value of atypical hemangiomas (arterial nodu-
lar enhancement type) at b 200, 500, 800, 1000 were 2.50,
2.40, 2.31, 2.25 · 103 mm2/s, respectively.
– Mean ADC value of atypical hemangiomas (delayed
enhancement type) at b 200, 500, 800, 1000 were 2.43,
2.33, 2.32, 1.97 · 103 mm2/s, respectively.
– Arterial nodular enhancement type of atypical hemangio-
mas showed higher ADC values than typical hemangiomas
and other type of atypical hemangiomas and it was statisti-
cally signiﬁcant.
– ADC value of normal liver tissue, typical and atypical heman-
giomas as well as signal intensity were shown in Table 2.
– Mean ADC value of normal liver tissue was signiﬁcantly
higher than hemangiomas at low b values (200, 500) while
mean ADC value of hemangiomas was signiﬁcantly higher
than normal liver tissue at high b values (800, 1000). . .
Graphs 1 and 2.
4. Discussion
Many studies have proposed that hepatic diffusion MR can
help to detect, characterize and distinguish benign from malig-
nant lesions based on diffusion signal intensity using different
b values and apparent diffusion coefﬁcient (ADC) measure-
ments (7). The measurement of diffusion coefﬁcient in vivo
may be affected by many factors, such as: parallel imaging
reduction factor, gradient imperfections, breath hold or respi-
ratory-triggered imaging, fat suppression technique, tempera-
ture, micro-circulation or perfusion, magnetic susceptibility
in the tissue, or other kinds of motion. DWI using high b value
reﬂects almost only diffusion, whereas low b value is composed
of both diffusion and perfusion. DWI is a useful adjunct to
routine liver imaging; it is fast, requires no intravenous con-
trast and is noninvasive (12–15).
Hemangiomas are characterized by an enlargement of the
extra-cellular space compared to the normal tissue. As a re-
sults, such lesions are expressed with free diffusion and ele-
vated ADC values. ADCs of hemangiomas are greater than
those of solid malignant lesions but are lower than those of
cysts, which is probably due to the vascular space and thus
blood ﬂow or perfusion within hemangiomas. However, degree
of perfusion might be affected by blood velocities in the vascu-
lar space of hemangioma (2,3).
Based on our imaging protocol, DW images were done with
b 0, b 200 and b 500 s/mm2, additional b values were obtained
(b 800, b 1000) as many authors (e.g. Zulkif Bozgeyik et al. (16)
and Bachir Taouli et al. (7)) advised for high b values moreof typical and atypical hemangiomas.
st T1WI Diﬀusion
tal Delayed b 0ﬁ b 1000 ADC map
ar enhancement Fill in Hyperintense Hyper or mixedb
cement Wash out Hyperintense Hyper or mixed
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Figure 1 (A–N) Female patient aged 43 Y. with typical hemangiomas (showing arterial peripheral nodular enhancement), came for
abdominal US complaining of colitis like symptoms. (A) pre contrast CT showing hypodense lesion at segment III of LT. liver lobe (arrow
head). (B–D) Triphasic contrast enhanced CT showing (A) arterial phase showing peripheral enhancement of the lesion and (B) portal
phase showing more peripheral enhancement of the lesion, (D) delayed phase showing isodensity of the lesion with liver tissue (complete
ﬁll in). (E) Diffusion MR at b 0 showing hyperintense signal of the lesion. (F) Diffusion MR at b 200, showing hyperintense signal of the
lesion. (G) Corresponding ADC map showing hyperintense signal of the lesion, ADC value of the lesion: 2.45 · 103 mm2/s. (H) Diffusion
MR at b 500, showing hyperintense signal of the lesion. (I) Corresponding ADC map showing hyperintense signal of the lesion, ADC
value of the lesion: 2.37 · 103 mm2/s. (J) Diffusion MR at b 800, showing hyperintense signal of the lesion. (K) Corresponding ADC map
showing hyperintense signal of the lesion, ADC value of the lesion: 2.28 · 103 mm2/s. (L) Diffusion MR at b 1000, showing hyperintense
signal of the lesion. (M) Corresponding ADC map showing hyperintense signal of the lesion, ADC value of the lesion: 2.11 · 103 mm2/s.
(N) Consequence diffusion MR images of the lesion using b 200, 500, 800, 1000, respectively showing hyperintense signal of the lesion.
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other authors (e.g. Nagihan Inan et al. (2)) reported that with
the b factor 500 s/mm2, no statistical signiﬁcance was obtained
in diffusion MR to distinguish hepatic hemangiomas from
metastases.
Zulkif Bozgeyika et al. (16) reported that it is well known
that low b values suffer from perfusion effect, but high b values
cause poor signal-to noise ratio (SNR). High b value (i.e.,
b-1000) was useful in depicting the lesions and differentiation
between normal liver tissue and hemangioma.In our study we combined successfully low and high b val-
ues in order to detect and characterize hemangiomas.
Satoshi Goshima et al. (17) in their study classiﬁed heman-
giomas into three enhancement types based on gadolinium-
enhanced MR imaging ﬁndings: type I, early (nodular)
enhancement type; type II, peripheral nodular enhancement
type; type III, delayed enhancement type.
In our study and on the basis of routine classiﬁcation and
frequency we classiﬁed hemangiomas into: typical lesions (cor-
responds to type II in the previous study, Figs. 1 and 2), and
Figure 2 (A–L) Female patient aged 28 Y. with typical hemangioma (showing arterial peripheral nodular enhancement), came for
abdominal US complaining of gastritis like symptoms. (A and B) Tri phasic post contrast MRI (arterial and delayed phases, respectively)
showing peripheral nodular enhancement of hepatic lesion in the arterial phase and ﬁlled in at the delayed phase. (C) Diffusion MR at b 0
showing hyperintense signal of the lesion. (D) Diffusion MR at b 200, showing hyperintense signal of the lesion. (E) Corresponding ADC
map showing mixed intensities of the lesion, ADC value of the lesion: 2.48 · 103 mm2/s. (F) Diffusion MR at b 500, showing
hyperintense signal of the lesion. (G) Corresponding ADC map showing mixed intensities of the lesion, ADC value of the lesion:
2.34 · 103 mm2/s. (H) Diffusion MR at b 800, showing hyperintense signal of the lesion. (I) Corresponding ADC map showing mixed
signal of the lesion, ADC value of the lesion: 2.32 · 103 mm2/s. (J) Diffusion MR at b 1000, showing hyperintense signal of the lesion. (K)
Corresponding ADC map showing hyperintense signal of the lesion, ADC value of the lesion: 2.12 · 103 mm2/s. (L) Consequence images
of the lesion in Diffusion MR using b 200, 500, 800, 1000, respectively showing hyperintense signal of the lesion.
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study, Fig. 3).
Benign lesions such as cystic and necrotic lesions show
hyperintense signal at b 0, hypointense signal at high b value
(more than 500), they show hyperintense signal at ADC maps.
Malignant solid lesions show hyper intense signal at both b 0
and high b values while in ADC maps, they show hypointense
signal. Simple lesions as cysts and hemangiomas show hyperin-
tense signal at the three diffusion sequences: b 0, high b value
and ADC maps (7)
In our study all hemangiomas (typical and atypical) showed
hyperintense signal at b 0, b 200, b 500, b 800 and b 1000 and
also at ADC maps they showed hyperintense or mixed signals,
thus they can be easily differentiated from other focal lesions.
In their study, Bachir Taouli and Dow-Mu Koh (7)reported
that hemangiomas showed bright signal at b 0 s/mm2 andattenuate progressively with increasing b values (till b 1000)
and the degree of signal attenuation of the liver and focal liver
lesions with increasing b value is non-linear, due to micro-
capillary perfusion. They explained this by the intravoxel
incoherent motion, or IVIM phenomenon, or pseudo-diffusion
effect. With IVIM, molecular diffusion can be separated from
perfusion, provided that a wide range of b values are used.
Understanding this phenomenon is important because the
choice of b values can determine the degree to which the
calculated ADC may be inﬂuenced by tissue perfusion at low
b values, as this may change the measurement of tissue
diffusivity. Also they explained why ADCs of liver lesions
reported in their literature calculated by using only lower b
values (100–200 s/mm2) are higher than those obtained by high
b values (more than 200 s/mm2) because the perfusion effects
are excluded in high b value.
Figure 3 (A–N) Female patient aged 36 Y. with atypical hemangioma (showing arterial nodular enhancement), came for gall bladder
US. (A) precontrast CT showing hypodense lesion at antero-superior segment of RT.liver lobe:segment VIII (arrow). (B–D) Triphasic
contrast enhanced CT showing, (A) arterial phase showing nodular enhancement of the lesion and (B) portal phase showing more nodular
enhancement of the lesion, (D) delayed phase showing faint wash out (arrows). (E) Diffusion MR at b 0 showing hyperintense signal of the
lesion. (F) Diffusion MR at b 200, showing hyperintense signal of the lesion. (G) corresponding ADC map showing mixed intensities of
the lesion, ADC value of the lesion: 2.51 · 103 mm2/s. H: Diffusion MR at b 500, showing hyperintense signal of the lesion. (I)
corresponding ADC map showing mixed intensities of the lesion, ADC value of the lesion: 2.41 · 103 mm2/s. (J) Diffusion MR at b 800,
showing hyperintense signal of the lesion. (K) corresponding ADC map showing hyperintense signal of the lesion, ADC value of the
lesion: 2.30 · 103 mm2/s. (L) Diffusion MR at b 1000, showing hyperintense signal of the lesion. (M) Corresponding ADC map showing
hyperintense signal of the lesion, ADC value of the lesion: 2.24 · 103 mm2/s. (N) Consequence images of the lesion in Diffusion MR
using b 200, 500, 800, 1000, respectively showing hyperintense signal of the lesion.
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strated hemangiomas with mild decreasing hyperintense signal
in diffusion MR as the b values increased (till b 1000).
In our study, all hemangiomas showed hyperintense signal
at b 0 that persisted with increasing b values till b 1000. No
gradual attenuation of the signal was noted. Thus there was
no IVIM effect in our study, this ﬁnding raises the question:
When is IVIM established?. . . we think this point needs further
study.
In our study at ADC maps, both typical and atypical
hemangiomas showed either hyperintense signal or mixed sig-
nals (hyperintense + isointense), hyperintense signal was more
evident at high b values (above 500). These results highlight theimportance of high b value in the characterization of
hemangiomas.
Many authors discussed the ADC value of hemangiomas at
different b values, Taouli et al. reported a mean of 2.95 in b va-
lue less than 500, Parikh et al. reported a mean of 2.04 at b 500,
Bruegel et al. reported a mean of 1.92 at b 600, Kim et al. re-
ported a mean of 2.91–3.03 at b value less than 846, Gourtsoyi-
anni et al. reported a mean of 1.9 at b 1000, Namimoto et al.
reported a mean of 1.95 at b 1200 (18–23).
Our study showed nearly similar results, at b 200 hemangio-
mas showed mean ADC of 2.47, at b 500, they showed mean
ADC of 2.36, at b 800 they showed mean ADC of 2.31 and
at b 1000, they showed mean ADC of 2.10 · 103 mm2/s.
Table 2 Showing mean ADC values (·103 mm2/s) and signal intensity of normal liver tissue, typical and atypical hemangiomas in
different b values.
Tissue/lesions
Diﬀusion B and ADC values Normal liver tissue (same lesion lobe) Typical hemangioma Atypical hemangioma
Peripheral nodular enhancement Nodular enhancement Delayed
b 200 Hyperintense signal Marked hyperintense
S.I. ADC value 3.31 2.46 2.50 2.43
b 500 Hyperintense signal Moderate hyperintense.
S.I. ADC value 2.53 2.36 2.40 2.33
b 800 Hyperintense signal Mild hyperintense
S.I. ADC value 1.79 2.29 2.31 2.32
b 1000 Hyperintense signal Slightly hyperintense
S.I. ADC value 1.26 2.10 2.25 1.97
Mean ADC value of normal liver tissue was signiﬁcantly higher than hemangiomas at low b values (200, 500) while mean ADC value of
hemangiomas was signiﬁcantly higher than normal liver tissue at high b values (800, 1000). . . Graphs 1 and 2.
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Graph 1 Showing mean ADC values of normal liver tissue, typical hemangiomas, nodular atypical hemangiomas and delayed atypical
hemangiomas at b 200. Note that mean ADC of normal liver tissue is signiﬁcantly higher than hemangiomas.
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Graph 2 Showing mean ADC values of normal liver tissue, typical hemangiomas, nodular atypical hemangiomas and delayed atypical
hemangiomas at b 1000. Note that mean ADC of hemangiomas is signiﬁcantly higher than normal liver tissue.
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values than normal liver tissue on low b values (less than
600). On the other hand, hemangiomas had higher ADC val-
ues than normal liver tissue on b-1000 images (16).
Our study showed similar results, in b 200 and b 500 ADC
values of normal liver tissue were higher than hemangiomas
(Graph 1) while in b 800 and b 1000 ADC values of normal li-
ver tissue were less than hemangiomas (Graph 2).
Applying a small diffusion weighting of b less than 100–
150 s/mm2 nulls the intra-hepatic vascular signal, creating the
so-called black blood images, which improve the detection offocal liver lesions, while higher b values (more than 500 s/
mm2) give diffusion information that helps focal liver lesion
characterization. When a high b factor is used, ADCs approx-
imate to the true value of the tissue in question, whereas when
a low b factor is applied, ADCs are affected by intra-voxel per-
fusion and are usually overestimated (7,24,25). . . This ﬁnding
explains why hemangioma ADC values are higher in lower b
values in the previous studies as well as in our study.
DWI may be helpful for distinguishing between some atyp-
ical hemangiomas and other lesions e.g. early-enhancing hem-
angioma and metastatic tumors of liver. For example, some
364 J.A. Mazroa, S.A. Elmogymetastatic tumors, particularly vascular metastasis, can mimic
hemangiomas on T1 and T2 weighted images. Using DWI and
measurement of ADC values may be useful to differentiate
metastases from hemangiomas especially in atypical masses
as malignancies have low ADC values and hypointense signal
on ADC maps (7). In our study all hemangiomas showed
hyperintense signal at low, high b values as well as ADC maps
allowing accurate differentiation between them and
malignancies.
Satoshi Goshima et al. (17) reported that mean hemangi-
oma ADCs at b 500 were 2.18 · 103 for type I (arterial nod-
ular enhancement), 1.86 · 103 for type II (arterial peripheral
enhancement) and 1.71 · 103 mm2/s for type III (delayed
enhancement) and reduced in the order type I–III. Statistically,
the mean ADC of type I was greater than that of types II
(P< .01) and III (P< .001), but types II and III were not sig-
niﬁcantly different.
Similarly our study showed signiﬁcant difference between
typical hemangiomas mean ADC and atypical hemangiomas
mean ADC. Nodular enhancement type of the atypical heman-
giomas showed the highest ADC values (at b 500 = 2.40), typ-
ical hemangiomas (peripheral nodular enhancement) showed
mean ADC of 2.36, the delayed enhancement type of atypical
hemangiomas showed the least ADC value: 2.33 · 103 mm2/s.
In Satoshi Goshima et al. (17) study, they found no corre-
lation between lesion size and enhancement type or ADC,
however, Kato et al. reported that the frequencies of early-
enhancing nodular hemangiomas are signiﬁcantly greater for
small lesions: less than 15 mm in diameter, and that the periph-
eral nodular enhancement and progressive ﬁll-in lesions are
signiﬁcantly greater for larger lesions more than 15 mm.
In our study lesions size ranged from 9 to 65 mm, and there
was no correlation between lesions size and pattern of contrast
enhancement or ADC values.
In the study of Frank et al. (26), they reported that the cut
off value of ADC to distinguish benign from malignant lesions
was 1.5 · 103 mm2/s with sensitivity of 91.3%. Kim et al. (27)
reported a threshold ADC value of 1.6 · 103 mm2/s to distin-
guish benign from malignant lesions with a sensitivity of 98%.
In the study of Tejas Parikh et al. (22), they found that
mean ADC values of malignant lesions were signiﬁcantly lower
than those of benign lesions: 1.39 · 103 mm2/sec. The mean
distribution of lesion ADCs was as follows: cysts,
2.54 · 103 mm2/s; hemangiomas, 2.04 · 103 mm2/s, liver ab-
scesses, 1.64 · 103 mm2/s; focal nodular hyperplasia and ade-
nomas, 1.49 · 103 mm2/s; liver metastases, 1.50 · 103 mm2/s
and HCCs, 1.31 · 103 mm2/s. They used a threshold ADC of:
1.60 · 103 mm2/s to differentiate benign from malignant
lesions.
In our study hemangiomas showed mean ADC of
2.10 · 103 mm2/s, thus it can be differentiated successfully
from other focal lesions.
Different authors mentioned the ADC value of normal liver
tissue, Bruegel et al. reported ADC of 1.24 · 103 mm2/s at b
600 while Gourtsoyianni et al. reported ADC of 1.25–
1.31 · 103 mm2/s at b 1000, our study showed mean ADC
of 1.26·103 mm2/s at b 1000 (18–23).
This study has several limitations. First further studies are
needed to explain the stability of hyperintense signal with
increasing b values, second we had no histologic conﬁrmation
of hemangioma (conﬁrmed only by their stability at the
6 months ultra-sound follow up), third the effect of chemother-apy (in patients with malignancy) on ADC values of heman-
giomas is unknown.
In conclusion, DWI is a sequence requiring no contrast
agent, it can successfully detect and characterize hepatic
hemangiomas whether typical or atypical, it provides qualita-
tive (signal intensity) and quantitative (ADC values) assess-
ment of all hemangiomas. The combination of diffusion
signal intensity & ADC maps and values successfully differen-
tiate hemangiomas from other focal lesions rather than signal
intensity changes in different b values.References
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